The prognostic role of apoptosis mediators in rectal adenocarcinoma

Hepato-Gastroenterology

Volumn 58, Issue 110-111, 2011, Pages 1490-1494

  Seicean, Radu ^a   Crişan, Doiniţa ^a   Boers, James E ^b   Mocan, Teodora ^a   Seicean, Andrada ^a   Funariu, Gheorghe ^a   Ciuce, Constantin ^a  

^a IULIU HATIEGANU UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

^b ISALA HOSPITAL   (Netherlands)

Author keywords

Apoptosis; P21; P53; Prognosis; Rectal cancer; Surgery

Indexed keywords

ANTINEOPLASTIC AGENT; CYCLIN D1; PROTEIN BCL 2; PROTEIN P21; PROTEIN P53;

ADULT; AGED; APOPTOSIS; ARTICLE; CANCER CHEMOTHERAPY; CANCER INVASION; CANCER SURVIVAL; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; IMMUNOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PATHOLOGY; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; RECTUM CARCINOMA; RETROSPECTIVE STUDY; TISSUE MICROARRAY;

EID: 83355169841     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: 10.5754/hge11130     Document Type: Article

References (21)

1. Schwandner O, Bruch HP, Broll R: P21, p27, cyclin D1 and p53 in rectal cancer: immunohistology with prognostic significance? Int J Colorectal Dis 2002; 17:11-19. (Pubitemid 41398985)
2. Rebischung C, Gérard JP, Gayet J, Thomas G, Hamelin R, Laurent-Puig P: Prognostic value of p53 mutations in rectal carcinoma.Int J Cancer 2002; 100:131-135. (Pubitemid 34666184)
3. Fernebro E, Halvarsson B, Baldetorp B, Nilbert M: Predominance of CIN versus MSI in the development of rectal cancer at young age. BMC Cancer 2002; 14:25.
4. Cascinu S, Graziano F, CatalanoV, Staccioli MP, Rossi MC, Baldelli AM, Barni S, Brenna A, Secondino S, Muretto P, Catalano G: An analysis of p53, BAX and vascular endothelial growth factor expression in node-positive rectal cancer. Relationships with tumour recurrence and event-free survival of patients treated with adjuvant chemoradiation.Br J Cancer 2002; 86:744-749. (Pubitemid 34250817)
5. Hilska M, Collan YU, O Laine VJ, Kössi J, Hirsimäki P, Laato M: The significance of tumor markers for proliferation and apoptosis in predicting survival in colorectal cancer. Dis Colon Rectum 2005; 48:2197-2208.
6. Soong R, Powell B, Elsaleh H, Gnanasampanthan G, Smith DR, Goh HS, Joseph D, Iacopetta B: Prognostic significance of TP53 gene mutation in 995 cases of colorectal carcinoma: influence of tumor site, stage, adjuvant therapy and type of mutation. Eur J Cancer 2000; 36:2053-2060.
7. Huerta S, Hrom J, Gao X, Saha D, Anthony T, Reinhart H, Kapur P: Tissue microarray constructs to predict a response to chemoradiation in rectal cancer. Dig Liver Dis 2010; 42:679-684.
8. Schwandner O, Schiedeck TH, Bruch HP, Duchrow M, Windhoevel U, Broll R: P53 and bcl-2 as significant predictors of reccurence and survival in rectal cancer. Eur J Cancer 2000; 36:348-356. (Pubitemid 30116731)
9. Morgan M, Koorey D, Painter D, Findlay M, Newland R, Chapuis P, Solomon M: P53 and DCC immunohistochemistry in rectal cancer surgery. Int J Colorectal Dis 2003; 18:188-195. (Pubitemid 36764163)
10. Jung A, Schrauder M, Oswald U, Knoll C, Sellberg P, Palmqvist R, Niedobitek G, Brabletz T, Kirchner T: The invasion front of human colorectal adenocarcinomas shows co-localisation of nuclear beta-catenin, cyclin D1 and p16 and is a region of low proliferation. Am J Pathology 2001; 159:1613-1617. (Pubitemid 33062503)
11. McKay JA, Douglas JJ, Ross VG, Curran S, Murray GI, Cassidy J, McLeod HL: Cyclin D1 protein expression and gene polymorphism in colorectal cancer. Int J Cancer 2000; 88:77-81.
12. Schwandner O, Bruch HP, Broll R: Prognostic significance of p21 and p27 protein, apoptosis, clinical and histologic factors in rectal cancer without lymph node metastases. Eur Surg Res 2002; 34: 389-396. (Pubitemid 36151456)
13. Kuremsky JG, Tepper JE, McLeod HL: Biomarkers for response to neoadjuvant chemoradiation for rectal cancer. Int J Radiat Oncol Biol Phys 2009; 74:673-688.
14. Sogawa N, Takiguchi N, Koda K, Oda K, Satomi D, Kato K, Ishikura H, Miyazaki M: Value of expression of p21WAF1/CIP1 as a prognostic factor in advanced middle and lower rectal cancer patients treated with preoperative radio-chemotherapy. Int J Oncol. 2002; 21:787-793.
15. Bhatavdekar JM, Patel DD, Ghosh N, Chikhlikar PR, Trivedi TI, Suthar TP, Doctor SS, Shah NG, Balar DB: Coexpression of bcl-2, c-myc, and p-53 oncoproteins as prognostic discriminants in patients with colorectal carcinoma. Dis Colon Rectum 1997; 40:785-790. (Pubitemid 27295049)
16. Klump B, Nehis O, Okech T, Hsieh CJ, Gaco V, Gittinger FS, Sarbia M, Borchard F, Greschniok A, Gruenagel HH, Porschen R, Gregor M: Molecular lesions in colorectal cancer: impact on prognosis? Int J Colorectal Dis 2004; 19:23-42.
17. Ishijima N, Miki C, Ishida T, Kinoshita T, Suzuki H: The immunohistochemical expression of bcl-2 oncoprotein in colorectal adenocarcinoma. Surg Today 1999; 29: 682-684. (Pubitemid 29361694)
18. Bertolini F, Bengala C, Losi L, Pagano M, Iachetta F, Dealis C, Jovic G, Depenni R, Zironi S, Falchi AM, Luppi G, Conte PF: Prognostic and predictive value of baseline and posttreatment molecular marker expression in locally advanced rectal cancer treated with neoadjuvant chemoradiotherapy. Int J Radiat Oncol Biol Phys 2007; 68:1455-1461. (Pubitemid 47176800)
19. Sadahiro S, Suzuki T, Maeda Y, Tanaka Y, Nakamura T, Saguchi T, Yasuda S, Makuuchi H, Murayama C, Ohizumi Y: Predictors of tumor downsizing and regression with preoperative radiotherapy alone and with concomitant tegafur/uracil (UFT) for resectable advanced rectal adenocarcinoma. Hepatogastroenterology 2007; 54:1107-1112. (Pubitemid 47013915)
20. de Bruin EC, van de Velde CJ, van de Pas S, Nagtegaal ID, van Krieken JH, Gosens MJ, Peltenburg LT, Medema JP, Marijnen CA: Prognostic value of apoptosis in rectal cancer patients of the dutch total mesorectal excision trial: radiotherapy is redundant in intrinsically high-apoptotic tumors. Clin Cancer Res 2006; 12:6432-6436. (Pubitemid 44799715)
21. Rödel C, Grabenbauer GG, Papadopoulos T, Bigalke M, Günther K, Schick C, Peters A, Sauer R, Rödel F: Apoptosis as a cellular predictor for histopathologic response to neoadjuvant radiochemotherapy in patients with rectal cancer. Int J Radiat Oncol Biol Phys 2002; 52:294-303.